Operational Quality Ratings Directory
Forensic Registry of Sovereign, Fortress, and Speculative Grade Assets
Access the definitive Operational Quality Rating Directory. This forensic index benchmarks global entities and mid-market firms using the Old York Protocol. Use the registry to compare enterprise durability across sectors and identify speculative-tier risks in the public and private markets.
Industry
- Aerospace & Defense 4
- Analytics 6
- Apparel 2
- Bank 14
- Beverages 3
- Car Manufacturing 7
- Chemicals 2
- Communication Services 1
- Consumer Defensive 6
- Consumer Discretionary 17
- Data 4
- Energy 8
- Entertainment 1
- Exchanges 5
- Farm & Heavy Construction Machinery 2
- Financial 27
- Hardware 1
- Healthcare 5
- Holding Company 3
- Home Improvement 2
- Indexes 2
- Industrial 19
- Information Technology 6
- Insurance 6
- Investment Banking 4
- Logistics 6
- Luxury 6
- Market Infrastructure 6
- Materials 2
- Oil & Gas 6
- Payment 3
- Personal Care & Beauty 1
- Pharmaceuticals 4
- Railroad 3
- Ratings 3
- Restaurants 4
- Retail 12
- Semi-Conductors 6
- Software 2
- Technology 13
- Telecommunications 4
- Utilities 3
- Waste Management 2
- Wealth Management 13
- Wireless & Broadband 4
Johnson & Johnson (JNJ) receives Old York Operational Quality (A) Rating for fiscal year 2025
View the (A) forensic audit of Johnson & Johnson (JNJ). Old York Financial analyzes $26.9B Owner Earnings, the Shockwave acquisition, and the impact of the $1.5B talc verdict. See why JNJ is the "Healthcare Sovereign" of 2026.
Novartis AG (NVS) receives Old York Operational Quality (A) Rating for fiscal year 2025
Read the (A) forensic audit of Novartis (NVS). Old York Financial analyzes $23.1B Owner Earnings, the 40% Core Margin milestone, and the 2026 Entresto patent cliff strategy. See why Novartis is the "Pure-Play" sovereign of 2026.
AbbVie Inc. (ABBV) receives Old York Operational Quality (A) Rating for fiscal year 2025
Access the (A) forensic audit of AbbVie (ABBV). Old York Financial analyzes $25.9B Owner Earnings, the post-Humira recovery, and the Skyrizi/Rinvoq growth engine. See why AbbVie is the "Cash Flow Utility" of 2026.
Eli Lilly and Company (LLY) receives Old York Operational Quality (AA) Rating for fiscal year 2025
Explore the (AA) forensic audit of Eli Lilly (LLY). Old York Financial analyzes $14.4B Owner Earnings, the $55B manufacturing moat, and the "Metabolic Sovereign" growth strategy for 2026.
UnitedHealth Group Inc. (UNH) receives Old York Operational Quality (A) Rating for fiscal year 2025
Access the forensic (A) rating for UnitedHealth (UNH). Old York Financial Analysis UNH’s $20.3B Owner Earnings, the Optum vertical moat, and the 2025 margin reset. See why the "Healthcare Sovereign" is a 2026 benchmark for defensive cash flow.